Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma

European Radiology

Volumn 22, Issue 9, 2012, Pages 1946-1954

  Nievelstein, R A J ^b   Van Ufford, H M E Quarles ^a   Kwee, T C ^b   Bierings, M B ^b   Ludwig, I ^b   Beek, F J A ^b   De Klerk, J M H ^c   Mali, W P Th M ^b   De Bruin, P W ^d   Geleijns, J ^d  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MEANDER MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Computed tomography; Malignant lymphoma; Medical imaging; Positron emission tomography; Radiation exposure

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER MORTALITY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; FEMALE; HODGKIN DISEASE; HUMAN; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION HAZARD; RISK ASSESSMENT; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LIFE EXPECTANCY; LIFE TABLES; LYMPHOMA; MALE; MIDDLE AGED; NETHERLANDS; POSITRON-EMISSION TOMOGRAPHY; PROPORTIONAL HAZARDS MODELS; RADIATION DOSAGE; RADIATION INJURIES; RADIOMETRY; RISK ASSESSMENT; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84864661510     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2447-9     Document Type: Article

References (46)

1. Kwee TC, Kwee RM, Nievelstein RA (2008) Imaging in staging of malignant lymphoma: A systematic review. Blood 111:504-516
2. Hoskin PJ (2003) PET in lymphoma: What are the oncologist's needs? Eur J Nucl Med Mol Imaging Supply 1:S37-S41
3. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Res 11:1860-1861
4. Armitage JO (2005) Staging non-Hodgkin lymphoma. CA Cancer J Clin 55:368-376
5. Hoh CK, Glaspy J, Rosen P et al (1997) Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 38:343-348
6. Buchmann I, Reinhardt M, Elsner K et al (2001) 2-(fluorine-18) fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer 91:889-899
7. Seam P, Juweid ME, Cheson BD (2007) The role of FDG-PET scans in patients with lymphoma. Blood 110:3507-3516
8. Juweid ME, Stroobants S, Hoekstra OS et al (2007) Use of positron emission tomography for response assessment of lymphoma: Consensus of the imaging subcommittee of international harmonization project in lymphoma. J Clin Oncol 25:571-578
9. Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579-586
10. Brenner D, Elliston C, Hall E, Berdon W (2001) Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 176:289-296
11. Brenner DJ, Elliston CD (2004) Estimated radiation risks potentially associated with full-body CT screening. Radiology 232:735-738
12. Linton OW, Mettler FA Jr (2003) National conference on dose reduction in CT, with an emphasis on pediatric patients. AJR Am J Roentgenol 181:321-329
13. Executive Summary Board on Radiation Effects Research-Division on Earth and Life Studies (2005) Health risks from exposure to low levels of ionizing radiation: BEIR VII-Phase 2. National Academy Press, Washington
14. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K (2003) Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 160:381-407
15. Pierce DA, Preston DL (2000) Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res 154:178-186
16. Preston DL, Ron E, Tokuoka S et al (2007) Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 168:1-64
17. National Council on Radiation Protection and Measurements (1997) Uncertainties in fatal cancer risk estimates used in radiation protection. Report 126. NCRP, Bethesda
18. Amis ES Jr, Butler PF, Applegate KE et al (2007) American college of radiology white paper on radiation dose in medicine. J Am Coll Radiol 4:272-284
19. Hall EJ, Brenner DJ (2008) Cancer risks from diagnostic radiology. Br J Radiol 81:362-378
20. Hillman BJ (2008) Radiation exposure and imaging utilization. J Am Coll Radiol 5:689-690
21. Mezrich R (2008) Are CT scans carcinogenic? J Am Coll Radiol 5:691-693
22. Mettler FA Jr, Thomadsen BR, Bhargavan M et al (2008) Medical radiation exposure in the U.S. in 2006: Preliminary results. Health Phys 95:502-507
23. Connors JM (2005) State-of-the-Art therapeutics: Hodgkin's lymphoma. J Clin Oncol 23:6400-6408
24. Ansell SM, Armitage J (2005) Non-Hodgkin lymphoma: Diagnosis and treatment. Mayo Clin Proc 80:1087-1097
25. Hennessy BT, Hanrahan EO, Daly PA (2004) Non-Hodgkin lymphoma: An update. Lancet Oncol 5:341-353
26. Brenner DJ, Shuryak I, Einstein AJ (2011) Impact of reduced patient life expectancy on potential cancer risks from radiologic imaging. Radiology 261:193-198
27. von der Weid NX (2008) Adult life after surviving lymphoma in childhood. Support Care Cancer 16:339-345
28. Chow LM, Nathan PC, Hodgson DC et al (2006) Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. J Clin Oncol 24:5735-5741
29. Illidge T, Tolan S (2008) Current treatment approaches for diffuse large B-cell lymphoma. Leuk Lymphoma 49:663-676
30. Feugier P, Van HA, Sebban C et al (2005) Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 23:4117-4126
31. Cristy M (1980) Mathematical phantoms representing children of various ages for use in estimates of internal dose. U.S. Nuclear Regulatory Commission Rep. NUREG/CR-1159 (also Oak Ridge National Laboratory Rep. ORNL/NUREG/TM-367)
32. Deak P, van Straten SM, Shrimpton PC, Zankl M, Kalender WA (2008) Validation of a Monte Carlo tool for patient-specific dose simulations in multi-slice computed tomography. Eur Radiol 18:759-772
33. Nievelstein RA, van Dam IM, van der Molen AJ (2010) Multidetector CT in children: Current concepts and dose reduction strategies. Pediatr Radiol 40:1324-1344
34. Nitt-Gray MF (2002) AAPM/RSNA physics tutorial for residents: Topics in CT. Radiation dose in CT. Radiographics 22:1541-1553
35. Valentin DJ (1998) Radiation dose to patients from radiopharmaceuticals (Addendum 2 to ICRP Publication 53). Ann ICRP 28:1
36. Ruotsalainen U, Suhonen-Polvi H, Eronen E et al (1996) Estimated radiation dose to the newborn in FDG-PET studies. J Nucl Med 37:387-393
37. NAS/NRC (2006) Health risks from exposure to low levels of ionising radiation: BEIR VII phase 2. Board on Radiation Effects Research National Research Council of the National Academies, Washington
38. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 37:1-332
39. Eurostat (2007) http://epp.eurostat.ec.europa.eu/
40. De Bruin ML, Sparidans J, van't Veer MB et al (2009) Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes. J Clin Oncol 27:4239-4246
41. Swerdlow S, Campo E, Harris N (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon
42. Brix G, Lechel U, Glatting G et al (2005) Radiation exposure of patients undergoing whole-body dual-modality 18 F-FDG PET/CT examinations. J Nucl Med 46:608-613
43. Kellenberger CJ, Miller SF, Khan M, Gilday DL, Weitzman S, Babyn PS (2004) Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children. Eur Radiol 14:1829-1841
44. Brennan DD, Gleeson T, Coate LE, Cronin C, Carney D, Eustace SJ (2005) A comparison of whole-body MRI and CT for the staging of lymphoma. AJR Am J Roentgenol 185:711-716
45. Kwee TC, Quarles van Ufford HM, Beek FJ et al (2009) Wholebody MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: Comparison to computed tomography. Invest Radiol 44:683-690
46. Quarles van Ufford HM, Kwee TC, Beek FJ et al (2011) Newly diagnosed lymphoma: Initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18 F-FDG PET/CT. AJR Am J Roentgenol 196:662-669